Fractures |
Broken Bones; Fracture |
Clinical Trial: Vertebroplasty for the Treatment of Fractures Due to Osteoporosis
This study is currently recruiting patients.
|
Purpose
Vertebroplasty is a procedure used to stabilize broken vertebrae, the bones that form the spine. This study will evaluate the effectiveness of vertebroplasty for the treatment of fractures due to osteoporosis.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Spinal Fractures Osteoporosis | Procedure: Percutaneous vertebroplasty | Phase III |
MedlinePlus related topics: Fractures; Neck Disorders and Injuries; Osteoporosis
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study
Official Title: Investigational Vertebroplasty Efficacy and Safety Trial (INVEST)
Expected Total Enrollment: 294
Spontaneous, atraumatic compression fractures due to osteoporosis occur in more than 700,000 patients per year. Pain associated with these fractures may be excruciating, but before the advent of percutaneous vertebroplasty, treatment options were limited. Analgesic medications, bed rest, and bracing have been the mainstays of treatment, but each of these therapies has substantial limitations.
Because of the dearth of viable treatment options for osteoporotic vertebral compression fractures, the practice of percutaneous vertebroplasty, which involves injection of polymethylmethacrylate (medical cement) into the fractured vertebra, has disseminated rapidly. However, evidence for the efficacy of percutaneous vertebroplasty is currently limited to uncontrolled, nonblinded, small case studies. Even though high rates of success are reported, with up to 90% of patients achieving substantial pain relief, these case studies have not accounted for numerous important potential biases, including the natural tendency for compression fractures to heal spontaneously, regression toward the mean (wherein patients seek medical attention when pain is maximum), and the placebo effect. This study will examine the clinical efficacy of percutaneous vertebroplasty for treatment of painful osteoporotic vertebral compression fractures.
Participants in this study will be randomly assigned to receive either percutaneous vertebroplasty or a sham procedure (placebo control group). Participants may have up to 2 spinal levels treated. Participants will be enrolled in the study for 2 years and will have study visits at entry and Months 1, 12, and 24. There will also be phone visits at Days 1, 2, 3, and 14 and Months 3 and 6. After Month 1, crossover from the placebo group to the vertebroplasty group will be allowed.
Eligibility
Ages Eligible for Study: 50 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Confirmed osteoporosis or osteopenia
- Vertebral compression fracture in vertebrae T4 through L5
- Pain not responsive to medical therapy
Exclusion Criteria:
Location and Contact Information
Minnesota
Mayo Clinic, Rochester, Minnesota, 55905, United States; Recruiting
David F. Kallmes, MD, Principal Investigator
David F. Kallmes, MD, Principal Investigator, Mayo Clinic
More Information
Publications
Kallmes DF, Jensen ME. Percutaneous vertebroplasty. Radiology. 2003 Oct;229(1):27-36. Review.
Record last reviewed: March 2005
Last Updated: March 21, 2005
Record first received: September 10, 2003
ClinicalTrials.gov Identifier: NCT00068822
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Alcohol and Bone Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases)
- American Academy of Orthopaedic Surgeons

Not Signed In -

